FDA repays drug industry by rushing risky meds to market

techinity July 01, 2018 0

As pharma companies underwrite three-fourths of the U.S. Food and Drug Administration’s budget for scientific reviews, the agency is increasingly fast-tracking expensive drugs with significant side effects and unproven health benefits.

from FOX News https://ift.tt/2MEMCOx

No comments

Subscribe to: Post Comments ( Atom )